Andera Partners

Primary contact
2, place Rio de Janeiro
75008 Paris
France
+33 1 85 73 64 00
2, place Rio de Janeiro
75008 Paris
France
+33 1 85 73 64 00
Key people ๐งโ๐คโ๐ง
- Vanessa Favier-Klak - COO
- Andrei Buzdugan - CFO
- Raymond W. Cohen - Andera Life Sciences' Venture Advisor
- Thierry Hercend - Andera Life Sciences' Venture Partner
- Loan Hoang-Sayag - Andera Life Sciences' Venture Partner
- Jan Van den Bossche - Andera Life Sciences' Partner
- Raphaรซl Wisniewski - Andera Life Sciences' Partner
- Sofia Ioannidou - Andera Life Sciences' Partner
- Gilles Nobรฉcourt - Andera Life Sciences' Partner
- Olivier Litzka - Andera Life Sciences' Partner
Investments ๐ธ
AgomAb Therapeutics
Developer of growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues
๐ Ghent, Belgium
Developer of growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues
๐ Ghent, Belgium
AM-Pharma
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
๐ Utrecht, Netherlands
A biopharmaceutical company developing alkaline phosphatase (AP) as a treatment for severe inflammatory diseases
๐ Utrecht, Netherlands
Ariceum Therapeutics
Developer of novel targeted radiopharmaceuticals for the treatment of cancer
๐ Berlin, Germany
Developer of novel targeted radiopharmaceuticals for the treatment of cancer
๐ Berlin, Germany
Artios Pharma
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
๐ Cambridge, United Kingdom
Developer of cancer treatments that target DNA Damage Response pathways to selectively kill cancer cells
๐ Cambridge, United Kingdom
Medical Microinstruments
Developer of a robotic system that enables surgeons to achieve better outcomes in microsurgery
๐ Pisa, Italy
Developer of a robotic system that enables surgeons to achieve better outcomes in microsurgery
๐ Pisa, Italy
MedLumics
Developer of a radiofrequency cardiac ablation catheter that allows the treatment of atrial fibrillation in real time
๐ Madrid, Spain
Developer of a radiofrequency cardiac ablation catheter that allows the treatment of atrial fibrillation in real time
๐ Madrid, Spain
T-knife Therapeutics
A next-gen T-cell receptor (TCR) company developing a pipeline of therapeutics for solid tumor patients
๐ Berlin, Germany
A next-gen T-cell receptor (TCR) company developing a pipeline of therapeutics for solid tumor patients
๐ Berlin, Germany
TriCares
Developer of a a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation
๐ Paris, France
Developer of a a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation
๐ Paris, France
Last update: September 14, 2022
Disclaimer: We can not guarantee that the information on this page is 100% correct. more